Back

Prognosis of Brugada patients according to their SCN5A genetic status.

12 April 2026 (13:30 - 14:15)
Organised by: Logo
Congress Presentation Part of: Brudaga syndrome diagnosis and management Clinical EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Professor Vincent Probst

University Hospital of Nantes, Nantes (France)

5 More presentations in this session

Presentation thumbnail
SMARTBrugada study: Smartwatch Marginosternal Application for Recording Type I Brugada pattern
Doctor A. Melpignano (Ferrara, IT)
Abstract Slides Video
Presentation thumbnail
Optimal duration of loop recorder monitoring: brugada syndrome as the exception
Doctor L. Cocchiara (Naples, IT)
Abstract Slides Video
Presentation thumbnail
Brugada atrial rhythm treatment strategy: explorative analysis from barts study
Professor M. Casella (Ancona, IT)
Abstract Slides Video
Presentation thumbnail
Long-term performance of different treatment approaches in Brugada Syndrome
Doctor C. Monaco (Bordeaux, FR)
Abstract Slides Video
Presentation thumbnail
Continous remote surveillance of arrhythmic patterns by implantable cardiac monitors (ICMs) in drug-induced Brugada type 1 patients
Doctor M. Ritacco (Parma, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Brudaga syndrome diagnosis and management

The Event

Event poster

EHRA 2026

12 April 2026 13:30 CET
You may be interested in
thumbnail
Congress Presentation
Genetic variants associated with ventricular arrhythmias during ajmaline test in Brugada syndrome
thumbnail
Congress Presentation
Long-term outcome and therapeutic evolution in Brugada syndrome: A 30-year single-center experience
thumbnail
Congress Presentation
Safety profile of ajmaline testing in Brugada syndrome: influence of SCNA5 mutations

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources